Troy A. Ignelzi, Chief Financial Officer at Karuna Therapeutics, Inc. (KRTX), sold 25,467 shares at $233.20 ($5.8M) on 2022-10-04, disclosed to the SEC on 2022-10-04.
Open-market sale of $5.8M KRTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $227.05 | 2,459 | $558K | 9.6% |
| 2 | $227.05 | 2,459 | $558K | 9.6% |
| 3 | $228.74 | 2,819 | $645K | 11.0% |
| 4 | $228.74 | 2,819 | $645K | 11.0% |
| 5 | $229.77 | 5,189 | $1.2M | 20.4% |
| 6 | $229.77 | 5,189 |
| $1.2M |
| 20.4% |
| 7 | $230.49 | 33 | $8K | 0.1% |
| 8 | $230.02 | 1,000 | $230K | 3.9% |
| 9 | $231.30 | 2,000 | $463K | 7.9% |
| 10 | $232.00 | 1,100 | $255K | 4.4% |
| 11 | $233.20 | 400 | $93K | 1.6% |
| Total | $229.30 avg | 25,467 | $5.8M | 100% |
| Filing → |
| KRTX | SELL | 2023-05-25 | $4.0M | — | Filing → |
| KRTX | SELL | 2023-02-23 | $1.1M | — | Filing → |
| KRTX | SELL | 2023-01-19 | $369K | — | Filing → |